EWY vs IBB
iShares MSCI South Korea ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.59% for EWY.
- • EWY pays a higher dividend yield (1.01%).
Side-by-side metrics
| Metric | EWY | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.01% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $24.47B | $9.09B |
YTD return | 87.94% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.40 | 0.69 |
P/E ratio | 18.26 | 24.89 |
Last price | $184.75 | $197.34 |
Inception | — | — |
Issuer | iShares | iShares |
EWY top holdings
| 000660.KS | SK Hynix Inc | 27.17% |
| 005930.KS | Samsung Electronics Co Ltd | 23.19% |
| 402340.KS | SK Square | 4.26% |
| 009150.KS | Samsung Electro-Mechanics Co Ltd | 3.63% |
| 005380.KS | Hyundai Motor Co | 1.74% |
| 105560.KS | KB Financial Group Inc | 1.58% |
| 028260.KS | Samsung C&T Corp | 1.19% |
| 055550.KS | Shinhan Financial Group Co Ltd | 1.19% |
| 034020.KS | Doosan Enerbility Co Ltd | 1.11% |
| 032830.KS | Samsung Life Insurance Co Ltd | 1.06% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About EWY
EWY (iShares MSCI South Korea ETF) is South Korean large and mid-cap equities. Managed by iShares, the fund carries $24.5B in assets under management, an expense ratio of 0.59%, a dividend yield of 1.01%. Its largest holding is SK Hynix Inc (000660.KS), which represents 27.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 4.7%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.